{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-098369","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.737716+00:00","generated_at":"2026-05-31T05:39:17.500331+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Entero Therapeutics signs LOI to license clinical trial compliance platform from DataVault Holdings","bullets":["Binding LOI for exclusive worldwide license to QOLPOM and FotoDigm clinical trial software from DataVault Holdings.","Consideration: $250,000 in convertible preferred shares priced at 180% of 5-day VWAP plus single-digit royalties on net sales.","Deal contingent on Entero securing at least $500,000 strategic investment; target up to $3M.","License intended to support Entero's planned Phase 3 latiglutenase trial for celiac disease and other GI indications.","Right of first refusal to fully acquire the assets; closing targeted by end of September 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-098369","json":"https://secwatch.observer/filing/0001104659-24-098369.json","markdown":"https://secwatch.observer/filing/0001104659-24-098369.md","text":"https://secwatch.observer/filing/0001104659-24-098369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924098369/0001104659-24-098369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924098369/tm2423688d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:39:17.500331+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}